Abstract
Ionizing radiation and the topoisomerase II inhibitor, teniposide (VM-26) both increase levels of the cyclin dependent kinase inhibitor, p21waf1/cip1 and promote dephosphorylation of the retinoblastoma tumor suppressor protein, Rb, in MCF-7 breast tumor cells, perturbations associated with suppression of the activity of the transcription factor, E2F. However, studies using an E2F binding site-luciferase reporter plasmid transfected into MCF-7 cells failed to demonstrate a reduction in E2F activity in response to VM-26 or to ionizing radiation. In contrast, E2F activity (both basal and E1A stimulated) could be suppressed by transfection with a plasmid expressing Rb, indicating that the capacity of E2F to bind to Rb and to be inactivated by Rb is functionally intact in MCF-7 cells. These findings in MCF-7 breast tumor cells suggest that E2F activity may not be directly susceptible to modulation by endogenous p21waf1/cip1 and Rb.
Footnotes
- Received March 14, 1997.
- Accepted May 19, 1997.
-
Send reprint requests to: Dr. David A. Gewirtz, Department of Medicine, Medical College of Virginia, P.O. Box 980230, Richmond, VA 23298. E-mail: gewirtz{at}gems.vcu.edu
-
↵1 Current affiliation: National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
-
This research was supported in part by Grant NRC0493080 from the Nuclear Regulatory Commission, Grant CA55815 from the National Cancer Institute, and United States Army Medical Research and Material Command Award DAMD 17-96-1-6167.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
